The HHS Evidence Building Plan, required by the Evidence Act, is a systematic plan for identifying and addressing policy questions relevant to the programs, policies, and regulations of the agency.
Evaluation
Evaluation and analysis provide essential evidence for HHS to understand how its programs work, for whom, and under what circumstances. HHS builds evidence through evaluation and analysis in order to inform decisions in budget, legislative, regulatory, strategic planning, program, and policy arenas. Given the breadth of work supported by HHS, many evaluations and analyses are conducted each year. These efforts range in scope, scale, design, and methodology, but all aim to understand how the effect of programs and policies and how they can be improved.
Across HHS, evaluation comes in many forms, including:
- Program evaluations using the most rigorous designs appropriate;
- Capacity-building initiatives to improve administrative data collection, accessibility, and use for management;
- Exploratory and preliminary quantitative and qualitative analysis to build evidence;
- Pilots and demonstrations; and
- Statistical analysis of factors related to health and human services programs and policies.
ASPE coordinates the evaluation community by regularly convening the HHS Evaluation & Evidence Policy Council, which builds capacity by sharing best practices and promising new approaches across HHS.
Noteworthy
Reports
Displaying 81 - 90 of 393. 10 per page. Page 9.
Advanced SearchReport
Certified Community Behavioral Health Clinics Demonstration Program: Report to Congress, 2020
This is the fourth annual report to Congress describing results from the Certified Community Behavioral Health Clinic (CCBHC) evaluation. This report summarizes changes in CCBHC rates and costs from demonstration year one (DY1) to DY2, performance on quality measures in DY1, and the extent to which states provided quality bonus payments (QBPs) to CCBHCs for DY1.
Research Brief
COVID-19 Vaccination Associated with Reductions in COVID-19 Mortality and Morbidity in the United States, and an Approach to Valuing these Benefits
This ASPE Research Report models the estimated reductions in COVID-19 cases, hospitalizations, and deaths associated with COVID-19 vaccination from December 2020 through July 2021. To download the Research Report, please download the PDF to the right under “Files”. To explore our dashboard that presents the Report’s results, please see below.
ASPE Issue Brief
Participation in the U.S. Social Safety Net: Coverage of Low-income Families, 2018
Participation in the social safety net varies widely across programs—from 15 percent among eligibles for subsidized child care (CCDF) to over 75 percent for Medicaid/CHIP and EITC.
Participation differs by race and ethnicity, yet patterns are not consistent. In general rates differ more across programs than between race-ethnic groups.
Report
Comparing Outcomes for Dual Eligible Beneficiaries in Integrated Care: Final Report
Dual eligible beneficiaries are an important subset of the Medicare and Medicaid populations because they have a high prevalence of chronic conditions and disabilities, substantial care needs, and high health care and long-term services and supports (LTSS) utilization and costs.
Report
Addressing Uncertainty in Regulatory Impact Analysis
In 2016, the U.S. Department of Health and Human Services finalized its Guidelines for Regulatory Impact Analysis under the leadership of its Assistant Secretary for Planning Evaluation and Analytics Team. The Guidelines discuss strategies for characterizing the uncertainty in quantified effects as well as the potential impacts of non-quantified effects.
Research Brief
Associations Between County-level Vaccination Rates and COVID-19 Outcomes Among Medicare Beneficiaries in Early 2021
The purpose of this study is to identify associations between COVID-19 infections, hospitalizations, and deaths among Medicare fee-for-service (FFS) beneficiaries and the proportion of the population fully vaccinated at the county-level between January and May 2021.
Report
Guidelines for Regulatory Impact Analysis Supplement: Addressing International Effects
This report extends the brief discussion of addressing international effects contained in the Department of Health and Human Service Guidelines for Regulatory Impact Analysis (2016). The purpose of this supplement is to expand that discussion and provide more detailed information on conducting such assessments.
Related Products:
Report
Valuing COVID-19 Mortality and Morbidity Risk Reductions in U.S. Department of Health and Human Services Regulatory Impact Analyses
This report develops an approach for valuing COVID-19 mortality and morbidity risk reductions based on the U.S. Department of Health and Human Services (HHS) Guidelines for Regulatory Impact Analysis. Valuing risk reductions associated with regulations or other policies that address the novel coronavirus disease 2019 (COVID-19) presents major challenges.
Department of Health & Human Services FY 2022 Evaluation Plan
As part of the Evidence Act, HHS is required to submit “an evaluation plan describing activities the agency plans to conduct pursuant to [its evidence-building plan].” Nine operating divisions within HHS and one staff division developed evaluation plans and included information on priority questions being examined by the agencies as well as data, methods, and challenges to addressing those ques